Dyne Therapeutics, Inc. (DYN)Healthcare | Biotechnology | Waltham, United States | NasdaqGS
20.41 USD
+0.50
(2.511%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 20.41 Short-term: ★★★★☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:55 p.m. EDT
Dyne Therapeutics presents a high-beta technical momentum play with a 'stop-run' pattern forming; the stock has severed its 52-week low cycle, and options flow is positioning for a break above resistance with significant support put buyers sitting below the 16-18 range. However, the strong negative autocorrelation stats and lack of fundamentals (negative EPS/PE) make this a speculative vehicle for price action alone, not a value bet. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.070028 |
| AutoARIMA | 0.070028 |
| MSTL | 0.070586 |
| AutoTheta | 0.071468 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.27 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.245 |
| Excess Kurtosis | -0.91 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 17.405 |
| Market Cap | 3,368,203,520 |
| Forward P/E | -6.73 |
| Beta | 1.29 |
| Website | https://www.dyne-tx.com |
As of April 18, 2026, 10:55 p.m. EDT: Call activity shows a distinct bullish bias with heavy OI buildup at $22.50 and $25.00 strikes for monthly expirations, while put volume is heavily concentrated below the current price (16.00, 17.50), suggesting a technical support play rather than bearish conviction. The Jan '27 put at 15.00 shows massive OI (152), creating a significant downside barrier, but call positioning in near-term weeks sways immediate flow sentiment towards upside momentum.
| Attribute | Value |
|---|---|
| 52 Week Change | 1.187567 |
| Address1 | 1,560 Trapelo Road |
| All Time High | 47.45 |
| All Time Low | 4.3 |
| Ask | 20.51 |
| Ask Size | 1 |
| Audit Risk | 6 |
| Average Daily Volume10 Day | 1,766,430 |
| Average Daily Volume3 Month | 2,156,722 |
| Average Volume | 2,156,722 |
| Average Volume10Days | 1,766,430 |
| Beta | 1.285 |
| Bid | 20.33 |
| Bid Size | 1 |
| Board Risk | 8 |
| Book Value | 5.893 |
| City | Waltham |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 10 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 20.41 |
| Current Ratio | 22.254 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 20.8 |
| Day Low | 19.92 |
| Debt To Equity | 17.405 |
| Display Name | Dyne Therapeutics |
| Earnings Timestamp | 1,772,458,200 |
| Earnings Timestamp End | 1,778,157,000 |
| Earnings Timestamp Start | 1,778,157,000 |
| Ebitda | -466,135,008 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -5.206 |
| Enterprise Value | 2,426,840,576 |
| Eps Current Year | -3.19251 |
| Eps Forward | -3.03427 |
| Eps Trailing Twelve Months | -3.47 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 781 786 8866 |
| Fifty Day Average | 17.3978 |
| Fifty Day Average Change | 3.0121994 |
| Fifty Day Average Change Percent | 0.1731368 |
| Fifty Two Week Change Percent | 118.7567 |
| Fifty Two Week High | 25.0 |
| Fifty Two Week High Change | -4.59 |
| Fifty Two Week High Change Percent | -0.18360001 |
| Fifty Two Week Low | 8.01 |
| Fifty Two Week Low Change | 12.4 |
| Fifty Two Week Low Change Percent | 1.5480648 |
| Fifty Two Week Range | 8.01 - 25.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,600,349,400,000 |
| Float Shares | 155,359,830 |
| Forward Eps | -3.03427 |
| Forward P E | -6.7264943 |
| Free Cashflow | -260,087,008 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 258 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00658 |
| Held Percent Institutions | 1.1511 |
| Implied Shares Outstanding | 165,027,119 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,020-09-17 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts. |
| Long Name | Dyne Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 3,368,203,520 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_608699906 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -446,214,016 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 3,369,028,634 |
| Number Of Analyst Opinions | 16 |
| Open | 20.63 |
| Operating Cashflow | -403,207,008 |
| Operating Margins | 0.0 |
| Overall Risk | 9 |
| Payout Ratio | 0.0 |
| Phone | 781 786 8230 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 20.41 |
| Post Market Time | 1,776,458,061 |
| Previous Close | 19.91 |
| Price Eps Current Year | -6.393089 |
| Price Hint | 2 |
| Price To Book | 3.4634311 |
| Profit Margins | 0.0 |
| Quick Ratio | 21.937 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.5 |
| Regular Market Change Percent | 2.5113 |
| Regular Market Day High | 20.8 |
| Regular Market Day Low | 19.92 |
| Regular Market Day Range | 19.92 - 20.8 |
| Regular Market Open | 20.63 |
| Regular Market Previous Close | 19.91 |
| Regular Market Price | 20.41 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 2,632,342 |
| Return On Assets | -0.31159002 |
| Return On Equity | -0.55708003 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 165,027,119 |
| Shares Percent Shares Out | 0.124 |
| Shares Short | 20,465,591 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 19,317,547 |
| Short Name | Dyne Therapeutics, Inc. |
| Short Percent Of Float | 0.1363 |
| Short Ratio | 7.68 |
| Source Interval | 15 |
| State | MA |
| Symbol | DYN |
| Target High Price | 50.0 |
| Target Low Price | 16.0 |
| Target Mean Price | 38.1875 |
| Target Median Price | 39.5 |
| Total Cash | 1,110,562,048 |
| Total Cash Per Share | 6.73 |
| Total Debt | 169,199,008 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.47 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 16.070375 |
| Two Hundred Day Average Change | 4.3396244 |
| Two Hundred Day Average Change Percent | 0.27003878 |
| Type Disp | Equity |
| Volume | 2,632,342 |
| Website | https://www.dyne-tx.com |
| Zip | 2,451 |